T.MAN Pharmaceutical PCL (BKK:TMAN) Marketable Securities: ฿354 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:TMAN T.MAN Pharmaceutical PCL BKK:TMAN
18 GF Score
Price ฿10.30
View Full Analysis

What is T.MAN Pharmaceutical PCL Marketable Securities?

T.MAN Pharmaceutical PCL BKK:TMAN -0.96% 18 Marketable Securities is ฿354 Mil as of Jun. 2026. GuruFocus rates BKK:TMAN with a GF Score™ of 18/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. T.MAN Pharmaceutical PCL's Marketable Securities for the quarter that ended in Jun. 2026 was ฿354 Mil.

T.MAN Pharmaceutical PCL's annual Marketable Securities increased from Dec. 2023 (฿0 Mil) to Dec. 2024 (฿450 Mil) but then declined from Dec. 2024 (฿450 Mil) to Dec. 2025 (฿352 Mil).

T.MAN Pharmaceutical PCL  (BKK:TMAN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

T.MAN Pharmaceutical PCL Marketable Securities Related Terms

T.MAN Pharmaceutical PCL Marketable Securities Historical Data

* Premium members only.

The historical data trend for T.MAN Pharmaceutical PCL's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T.MAN Pharmaceutical PCL Marketable Securities Chart

T.MAN Pharmaceutical PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Marketable Securities
0.00 0.00 450.00 352.30

T.MAN Pharmaceutical PCL Quarterly Data
Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 251.38 251.38 352.30 353.68 353.68
BKK:TMAN
18GF Score
T.MAN Pharmaceutical PCL BKK:TMAN
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

T.MAN Pharmaceutical PCL Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ฿354 Mil mean?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Marketable Securities of ฿354 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on T.MAN Pharmaceutical PCL and its competitors.
Is T.MAN Pharmaceutical PCL's Marketable Securities too high?
T.MAN Pharmaceutical PCL's current Marketable Securities is ฿354 Mil. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Marketable Securities compare to ZTS and UTHR?
T.MAN Pharmaceutical PCL's Marketable Securities of ฿354 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on T.MAN Pharmaceutical PCL and its competitors. T.MAN Pharmaceutical PCL's current Marketable Securities is ฿354 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Marketable Securities of ฿354 Mil. The current Marketable Securities is ฿354 Mil. T.MAN Pharmaceutical PCL's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Marketable Securities is ฿354 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

T.MAN Pharmaceutical PCL Business Description

Address Bangkhunthian Road, 69/1 Soi Bangkhunthian 14, Samaedum Subdistrict, Bangkhunthian District, Bangkok, THA, 10150
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
18GF Score

Get the complete analysis for BKK:TMAN

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿10.30
Price